메뉴 건너뛰기




Volumn 213, Issue 2, 2016, Pages 199-205

Human papillomavirus vaccination of boys and extended catch-up vaccination: Effects on the resilience of programs

Author keywords

catch up; coverage reduction; gender neutral; human papillomavirus vaccination; resilience

Indexed keywords

WART VIRUS VACCINE;

EID: 84959914078     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv368     Document Type: Article
Times cited : (58)

References (38)
  • 1
    • 84988850433 scopus 로고    scopus 로고
    • Vaccinate boys as well as girls against HPV: It works, and it may be cost effective
    • Prue G. Vaccinate boys as well as girls against HPV: it works, and it may be cost effective. BMJ 2014; 349:g4834.
    • (2014) BMJ , vol.349 , pp. g4834
    • Prue, G.1
  • 4
    • 84875976587 scopus 로고    scopus 로고
    • Optimal vaccine allocation for the early mitigation of pandemic influenza
    • Matrajt L, Halloran ME, Longini Jr. I.M. Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS Comput Biol 2013; 9:e1002964.
    • (2013) PLoS Comput Biol , vol.9 , pp. e1002964
    • Matrajt, L.1    Halloran, M.E.2    Longini, I.M.3
  • 6
    • 84959903301 scopus 로고    scopus 로고
    • Ministerio de salud y protección social grupo inmunoprevenibles
    • Bogota, Colombia: Ministerio de Salud y Protección Social
    • Ministerio de Salud y Protección Social Grupo Inmunoprevenibles. Jornada de vacunación contra el virus del papiloma humano. Bogota, Colombia: Ministerio de Salud y Protección Social, 2014:1-3.
    • (2014) Jornada de Vacunación Contra El Virus Del Papiloma Humano , pp. 1-3
  • 7
    • 84867401358 scopus 로고    scopus 로고
    • Measles still spreads in Europe: Who is responsible for the failure to vaccinate?
    • Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate?. Clin Microbiol Infect 2012; 18(suppl 5):50-6.
    • (2012) Clin Microbiol Infect , vol.18 , pp. 50-56
    • Carrillo-Santisteve, P.1    Lopalco, P.L.2
  • 10
    • 84902602776 scopus 로고    scopus 로고
    • Tuberculosis control in New York City-A changing landscape
    • Macaraig M, Burzynski J, Varma JK. Tuberculosis control in New York City-A changing landscape. N Engl J Med 2014; 370:2362-5.
    • (2014) N Engl J Med , vol.370 , pp. 2362-2365
    • Macaraig, M.1    Burzynski, J.2    Varma, J.K.3
  • 11
    • 60349094121 scopus 로고    scopus 로고
    • Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
    • Sander B, Nizam A, Garrison LP Jr, Postma MJ, Halloran ME, Longini Jr. I.M. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health 2009; 12:226-33.
    • (2009) Value Health , vol.12 , pp. 226-233
    • Sander, B.1    Nizam, A.2    Garrison, L.P.3    Postma, M.J.4    Halloran, M.E.5    Longini, I.M.6
  • 12
    • 64349098448 scopus 로고    scopus 로고
    • Introduction of human papillomavirus (HPV) vaccination in Sweden
    • pii
    • Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill 2009; 14:pii:19119.
    • (2009) Euro Surveill , vol.14 , pp. 19119
    • Tegnell, A.1    Dillner, J.2    Andrae, B.3
  • 13
    • 84876008961 scopus 로고    scopus 로고
    • Quadrivalent human papillomavirus vaccine effectiveness: A Swedish national cohort study
    • Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013; 105: 469-74.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 469-474
    • Leval, A.1    Herweijer, E.2    Ploner, A.3
  • 15
    • 84896730323 scopus 로고    scopus 로고
    • Type-specific human papillomavirus biological features: Validated model-based estimates
    • Baussano I, Elfstrom KM, Lazzarato F, et al. Type-specific human papillomavirus biological features: validated model-based estimates. PLoS One 2013; 8:e81171.
    • (2013) PLoS One , vol.8 , pp. e81171
    • Baussano, I.1    Elfstrom, K.M.2    Lazzarato, F.3
  • 16
    • 84892463356 scopus 로고    scopus 로고
    • Upscaling human papillomavirus vaccination in high-income countries: Impact assessment based on transmission model
    • Baussano I, Dillner J, Lazzarato F, Ronco G, Franceschi S. Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model. Infect Agent Cancer 2014; 9:4.
    • (2014) Infect Agent Cancer , vol.9 , pp. 4
    • Baussano, I.1    Dillner, J.2    Lazzarato, F.3    Ronco, G.4    Franceschi, S.5
  • 17
    • 84873365473 scopus 로고    scopus 로고
    • High-Throughput monitoring of human papillomavirus type distribution
    • Soderlund-Strand A, Dillner J. High-Throughput monitoring of human papillomavirus type distribution. Cancer Epidemiol Biomarkers Prev 2013; 22:242-50.
    • (2013) Cancer Epidemiol Biomarkers Prev , vol.22 , pp. 242-250
    • Soderlund-Strand, A.1    Dillner, J.2
  • 19
    • 84862771858 scopus 로고    scopus 로고
    • Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study
    • Carozzi F, Ronco G, Gillio-Tos A, et al. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur J Cancer 2012; 48:1633-7.
    • (2012) Eur J Cancer , vol.48 , pp. 1633-1637
    • Carozzi, F.1    Ronco, G.2    Gillio-Tos, A.3
  • 20
    • 79960122395 scopus 로고    scopus 로고
    • Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica
    • Vaccarella S, Franceschi S, Herrero R, et al. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011; 204:385-90.
    • (2011) J Infect Dis , vol.204 , pp. 385-390
    • Vaccarella, S.1    Franceschi, S.2    Herrero, R.3
  • 21
    • 84879798247 scopus 로고    scopus 로고
    • Clinical trials of human papillomavirus vaccines and beyond
    • Lehtinen M, Dillner J. Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol 2013; 10:400-10.
    • (2013) Nat Rev Clin Oncol , vol.10 , pp. 400-410
    • Lehtinen, M.1    Dillner, J.2
  • 22
    • 79551558109 scopus 로고    scopus 로고
    • Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
    • Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401-11.
    • (2011) N Engl J Med , vol.364 , pp. 401-411
    • Giuliano, A.R.1    Palefsky, J.M.2    Goldstone, S.3
  • 23
    • 84923039975 scopus 로고    scopus 로고
    • A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
    • Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372:711-23.
    • (2015) N Engl J Med , vol.372 , pp. 711-723
    • Joura, E.A.1    Giuliano, A.R.2    Iversen, O.E.3
  • 24
    • 84908087933 scopus 로고    scopus 로고
    • Human papillomavirus vaccines: WHO position paper, October 2014
    • World Health Organization.
    • World Health Organization. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014; 89:465-91.
    • (2014) Wkly Epidemiol Rec , vol.89 , pp. 465-491
  • 25
    • 85026952706 scopus 로고    scopus 로고
    • Socialstyrelsen. Accessed 2 March
    • Socialstyrelsen. Tvådosschema för HPV-vaccin planeras från årsskiftet. http://www.socialstyrelsen.se/nyheter/2014september/tvadosschemaforhpv-vaccinplane rasfranarsskiftet. Accessed 2 March 2015.
    • (2015) Tvådosschema för HPV-vaccin Planeras Från Årsskiftet
  • 26
    • 84896881444 scopus 로고    scopus 로고
    • Cancer incidence and mortality worldwide. IARC CancerBase. No. 11. Lyon. France: International Agency for Research on Cancer
    • Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase. No. 11. Lyon, France: International Agency for Research on Cancer, 2013.
    • (2013) GLOBOCAN 2012 v1.0
    • Ferlay, J.1    Soerjomataram, I.2    Ervik, M.3
  • 27
    • 80155195391 scopus 로고    scopus 로고
    • Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm Sweden before public HPV vaccination
    • Du J, Nasman A, Carlson JW, Ramqvist T, Dalianis T. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination. Acta Oncol 2011; 50:1215-9.
    • (2011) Acta Oncol , vol.50 , pp. 1215-1219
    • Du, J.1    Nasman, A.2    Carlson, J.W.3    Ramqvist, T.4    Dalianis, T.5
  • 28
    • 84855163224 scopus 로고    scopus 로고
    • Sexspecific immunization for sexually transmitted infections such as human papillomavirus: Insights from mathematical models
    • Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J. Sexspecific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med 2011; 8:e1001147.
    • (2011) PLoS Med , vol.8 , pp. e1001147
    • Bogaards, J.A.1    Kretzschmar, M.2    Xiridou, M.3    Meijer, C.J.4    Berkhof, J.5    Wallinga, J.6
  • 29
    • 84959912497 scopus 로고    scopus 로고
    • Background to a vaccination programme for the human papillomavirus in Sweden 2007
    • Socialstyrelsen
    • Socialstyrelsen. Background to a vaccination programme for the human papillomavirus in Sweden 2007. Stockholm, Sweden: National Board of Health and Welfare, 2008.
    • (2008) Stockholm, Sweden: National Board of Health and Welfare
  • 30
  • 31
    • 84919390466 scopus 로고    scopus 로고
    • Change in population prevalences of human papillomavirus after initiation of vaccination: The high-Throughput HPV monitoring study
    • Soderlund-Strand A, Uhnoo I, Dillner J. Change in population prevalences of human papillomavirus after initiation of vaccination: the high-Throughput HPV monitoring study. Cancer Epidemiol Biomarkers Prev 2014; 23:2757-64.
    • (2014) Cancer Epidemiol Biomarkers Prev , vol.23 , pp. 2757-2764
    • Soderlund-Strand, A.1    Uhnoo, I.2    Dillner, J.3
  • 32
    • 84866628242 scopus 로고    scopus 로고
    • Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-Analysis
    • Malagon T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-Analysis. Lancet Infect Dis 2012; 12:781-9.
    • (2012) Lancet Infect Dis , vol.12 , pp. 781-789
    • Malagon, T.1    Drolet, M.2    Boily, M.C.3
  • 34
    • 84864521576 scopus 로고    scopus 로고
    • HPV vaccination for boys? Talking economic sense
    • Garattini L, van de Vooren K. HPV vaccination for boys?. Talking economic sense. J Sex Med 2012; 9:2195-6.
    • (2012) J Sex Med , vol.9 , pp. 2195-2196
    • Garattini, L.1    Van De Vooren, K.2
  • 36
    • 67651042998 scopus 로고    scopus 로고
    • HPV vaccine for all
    • Michels KB, zur Hausen H. HPV vaccine for all. Lancet 2009; 374:268-70.
    • (2009) Lancet , vol.374 , pp. 268-270
    • Michels, K.B.1    Zur Hausen, H.2
  • 37
    • 84926077197 scopus 로고    scopus 로고
    • UK committee recommends HPV vaccination for men who have sex with men
    • Kirby T. UK committee recommends HPV vaccination for men who have sex with men. Lancet Oncol 2015; 16:e7.
    • (2015) Lancet Oncol , vol.16 , pp. e7
    • Kirby, T.1
  • 38
    • 79952487617 scopus 로고    scopus 로고
    • Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study
    • Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377:932-40.
    • (2011) Lancet , vol.377 , pp. 932-940
    • Giuliano, A.R.1    Lee, J.H.2    Fulp, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.